Articles | AmbioPharm

Microwave-assisted SPPS: From discovery to commercial production

January 18, 2022

Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis

September 28, 2021

peptide drug approvals

An Approval for Apellis

June 8, 2021

Bivalirudin (“Angiomax”): Rescue Therapy in Covid Cases

May 5, 2021

AmbioPharm 100 Years of Insulin

100 Years of Insulin: A Triumph of Science

May 4, 2021

AmbioPharm Green Chemistry

Green Peptide Chemistry and Sustainability Publication

April 20, 2021

Streamlining the Path to Peptide Market Supply

March 17, 2021

New Peptide Toxin-Derived KV1.3 Channel Inhibitor Publication in the British Journal of Pharmacology

March 2, 2021

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services

Have a Peptide project?

SUBMIT YOUR REQUIREMENTS